weight gain
-
anti-obesity medicine, antipsychotics, bipolar disorder, British Journal of Psychiatry Open, Editor Simon Bradstreet, GLP-1 receptor agonists, GLP1, meta-analysis, metabolic health, mortality gap, obesity, physical health, psychosis, schizophrenia, semaglutide, systematic review, tirzepatide, weight gain, weight lossNew heavyweight contender against antipsychotic weight gain? Semaglutide enters the ring
Antipsychotics can be life-changing medications, but they often come with an unwelcome…
-
antipsychotics, cardiometabolic health, cardiovascular disease, cardiovascular screening, clinical prediction model, cohort study, early intervention in psychosis, Editor Eimear Foley, metabolic syndrome, mixed methods, mortality gap, obesity, personalised care, precision psychiatry, prediction, preventive healthcare, psychosis, risk factors, risk prediction, schizophrenia, severe mental illness, shared decision making, The Lancet Psychiatry, type 2 diabetes, weight gainPsychosis and metabolic risk: PsyMetRiC 2.0 reaches the clinic
Compared to the general population, individuals with psychosis have a 15-year reduced…
-
antipsychotics, British Journal of Psychiatry, cardiometabolic risk, causal inference, comorbidities, comorbidity, early intervention, Editor Eimear Foley, first episode psychosis, haloperidol, mediation analysis, metabolic health, mortality gap, obesity, olanzapine, personalised medicine, physical health inequalities, precision psychiatry, prediction modelling, psychosis, randomised controlled trial, schizophrenia, side effects, topical, weight gainCan we predict and prevent weight gain in early psychosis?
On average, people with psychosis die 15 years earlier than the general…
